Articoli di riviste sul tema "Anthracyclines"
Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili
Vedi i top-50 articoli di riviste per l'attività di ricerca sul tema "Anthracyclines".
Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.
Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.
Vedi gli articoli di riviste di molte aree scientifiche e compila una bibliografia corretta.
Sorensen, K., G. Levitt, D. Sebag-Montefiore, C. Bull e I. Sullivan. "Cardiac function in Wilms' tumor survivors." Journal of Clinical Oncology 13, n. 7 (luglio 1995): 1546–56. http://dx.doi.org/10.1200/jco.1995.13.7.1546.
Testo completoKrook, James Edward, Akhil Kumar, Marc L. Fishman, William S. Shimp, Laura Rose Bobolts, Val Fishman, Sharon Davis et al. "Community use of anthracyclines in metastatic breast cancer (MBC)." Journal of Clinical Oncology 31, n. 15_suppl (20 maggio 2013): 1080. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.1080.
Testo completoKumar, Akhil, Marc L. Fishman, William S. Shimp, Laura Rose Bobolts, James Edward Krook, Val Fishman, Sharon Davis et al. "Community use of anthracyclines for adjuvant HER2-positive breast cancer (BC)." Journal of Clinical Oncology 31, n. 15_suppl (20 maggio 2013): e11609-e11609. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.e11609.
Testo completoNeppelenbroek, Suzanne I. M., Yvonne M. Geurts, Berthe M. P. Aleman, Cecile P. M. Janus, Saskia E. Rademakers, Roel J. de Weijer, Richard W. M. Van Der Maazen et al. "Anthracycline exposure and breast cancer risk in female Hodgkin lymphoma survivors." Journal of Clinical Oncology 39, n. 15_suppl (20 maggio 2021): 12074. http://dx.doi.org/10.1200/jco.2021.39.15_suppl.12074.
Testo completoBlanco, Javier G., Can-Lan Sun, Wendy Landier, Lu Chen, Diego Esparza-Duran, Wendy Leisenring, Allison Mays et al. "Anthracycline-Related Cardiomyopathy After Childhood Cancer: Role of Polymorphisms in Carbonyl Reductase Genes—A Report From the Children's Oncology Group". Journal of Clinical Oncology 30, n. 13 (1 maggio 2012): 1415–21. http://dx.doi.org/10.1200/jco.2011.34.8987.
Testo completoRybczyńska-Tkaczyk, Kamila. "Enhanced Efficiency of the Removal of Cytostatic Anthracycline Drugs Using Immobilized Mycelium of Bjerkandera adusta CCBAS 930". Molecules 26, n. 22 (12 novembre 2021): 6842. http://dx.doi.org/10.3390/molecules26226842.
Testo completoTorkkell, Sirke, Tero Kunnari, Kaisa Palmu, Juha Hakala, Pekka Mäntsälä e Kristiina Ylihonko. "Identification of a Cyclase Gene Dictating the C-9 Stereochemistry of Anthracyclines from Streptomyces nogalater". Antimicrobial Agents and Chemotherapy 44, n. 2 (1 febbraio 2000): 396–99. http://dx.doi.org/10.1128/aac.44.2.396-399.2000.
Testo completoKrell, J., C. Harper-Wynne, D. Miles, V. Misra, S. Cleator, D. Krell e C. Palmieri. "What is the evidence for rechallenging with anthracyclines or taxanes in metastatic breast cancer? A review of the data". Journal of Clinical Oncology 27, n. 15_suppl (20 maggio 2009): 1072. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.1072.
Testo completoChen, Wei-Wu, Twan Ying Chang, Shu-Min Huang, Ching-Hung Lin, Chiun Hsu, Ann-Lii Cheng e Yen-Shen Lu. "The first two lines of chemotherapy for anthracycline-naïve metastatic breast cancer: A comparative study of efficacy between anthracyclines and nonanthracyclines." Journal of Clinical Oncology 30, n. 15_suppl (20 maggio 2012): 1061. http://dx.doi.org/10.1200/jco.2012.30.15_suppl.1061.
Testo completoGianni, Luca, Larry Norton, Norman Wolmark, Thomas M. Suter, Gianni Bonadonna e Gabriel N. Hortobagyi. "Role of Anthracyclines in the Treatment of Early Breast Cancer". Journal of Clinical Oncology 27, n. 28 (1 ottobre 2009): 4798–808. http://dx.doi.org/10.1200/jco.2008.21.4791.
Testo completoSuarato, Antonino, Francesco Angelucci e Cristina Geroni. "Ring-B Modified Anthracyclines". Current Pharmaceutical Design 5, n. 3 (marzo 1999): 217–27. http://dx.doi.org/10.2174/1381612805666230109215627.
Testo completoDozic, Sanela, Erin J. Howden, James R. Bell, Kimberley M. Mellor, Lea M. D. Delbridge e Kate L. Weeks. "Cellular Mechanisms Mediating Exercise-Induced Protection against Cardiotoxic Anthracycline Cancer Therapy". Cells 12, n. 9 (4 maggio 2023): 1312. http://dx.doi.org/10.3390/cells12091312.
Testo completoGennari, A., M. Sormani, M. Costantini, P. Pronzato, R. Rosso e P. Bruzzi. "Anthracycline regimens versus CMF in the adjuvant treatment of early breast cancer (EBC): A matter of difference". Journal of Clinical Oncology 24, n. 18_suppl (20 giugno 2006): 569. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.569.
Testo completoEgas Bejar, Daniela E., Joy M. Fulbright, Fernando F. Corrales-Medina, Mary E. Irwin, Blake Johnson e Joya Chandra. "Uncovering Cardioprotective Strategies For Anthracycline Therapy By Analysis Of Redox and Apoptotic Effects". Blood 122, n. 21 (15 novembre 2013): 1293. http://dx.doi.org/10.1182/blood.v122.21.1293.1293.
Testo completoBehrouzian, Mahsa, Babak Najibi, Sabahat Haghi, Chehreh Mahdavi, Kaveh Jaseb e Ehsan Ghaedi. "Prevalence of Major Cardiac Events of Anthracycline-Induced Cardiotoxicity in Southwestern Iran: Different Response Patterns to Cumulative Dose". Current Drug Therapy 15, n. 1 (14 gennaio 2020): 78–84. http://dx.doi.org/10.2174/1574885514666190311145607.
Testo completoKhan, Meraj A., Adam D’Ovidio, Harvard Tran e Nades Palaniyar. "Anthracyclines Suppress Both NADPH Oxidase- Dependent and -Independent NETosis in Human Neutrophils". Cancers 11, n. 9 (7 settembre 2019): 1328. http://dx.doi.org/10.3390/cancers11091328.
Testo completode Vries, Elisabeth G. E., e Jan G. Zijlstra. "Morpholinyl anthracyclines: Option for reversal of anthracycline resistance". European Journal of Cancer and Clinical Oncology 26, n. 6 (gennaio 1990): 659–60. http://dx.doi.org/10.1016/0277-5379(90)90110-f.
Testo completoMarinello, Jessica, Maria Delcuratolo e Giovanni Capranico. "Anthracyclines as Topoisomerase II Poisons: From Early Studies to New Perspectives". International Journal of Molecular Sciences 19, n. 11 (6 novembre 2018): 3480. http://dx.doi.org/10.3390/ijms19113480.
Testo completoMontaigne, David, Christopher Hurt e Remi Neviere. "Mitochondria Death/Survival Signaling Pathways in Cardiotoxicity Induced by Anthracyclines and Anticancer-Targeted Therapies". Biochemistry Research International 2012 (2012): 1–12. http://dx.doi.org/10.1155/2012/951539.
Testo completoQiao, Xiaohang, Sabina Y. van der Zanden, Dennis P. A. Wander, Daniel M. Borràs, Ji-Ying Song, Xiaoyang Li, Suzanne van Duikeren et al. "Uncoupling DNA damage from chromatin damage to detoxify doxorubicin". Proceedings of the National Academy of Sciences 117, n. 26 (17 giugno 2020): 15182–92. http://dx.doi.org/10.1073/pnas.1922072117.
Testo completoHerzig, R. H., H. M. Lazarus, S. N. Wolff, G. L. Phillips e G. P. Herzig. "High-dose cytosine arabinoside therapy with and without anthracycline antibiotics for remission reinduction of acute nonlymphoblastic leukemia." Journal of Clinical Oncology 3, n. 7 (luglio 1985): 992–97. http://dx.doi.org/10.1200/jco.1985.3.7.992.
Testo completoLevina, V. D., M. G. Poltavskaya, V. P. Sedov, P. Sh Chomakhidze, L. V. Bolotina, T. I. Deshkina, M. D. Kuklina et al. "The role of left ventricle global longitudinal srain in prediction of chemotherapy — induced cardiotoxicity in breast cancer patients treated by low and moderate cumulative doses of anthracyclines". Medical alphabet, n. 33 (12 gennaio 2023): 19–26. http://dx.doi.org/10.33667/2078-5631-2022-33-19-26.
Testo completoAl-Batran, S., M. Scholz e E. Jäger. "Anthracycline-rechallenge using pegylated liposomal doxorubicin (PLD) in previously treated patients with metastatic breast cancer (MBC): A meta-analysis using pooled individual data from four prospective trials". Journal of Clinical Oncology 27, n. 15_suppl (20 maggio 2009): 1047. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.1047.
Testo completoMenna, Pierantonio, e Emanuela Salvatorelli. "Primary Prevention Strategies for Anthracycline Cardiotoxicity: A Brief Overview". Chemotherapy 62, n. 3 (2017): 159–68. http://dx.doi.org/10.1159/000455823.
Testo completoVeiga, Lene H. S., Rochelle E. Curtis, Lindsay M. Morton, Diana Withrow, Rebecca M. Howell, Susan A. Smith, Rita Weathers et al. "Combined effect of radiotherapy and anthracyclines on risk of breast cancer among female childhood cancer survivors: A report from the Childhood Cancer Survivor Study (CCSS)." Journal of Clinical Oncology 37, n. 15_suppl (20 maggio 2019): 10053. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.10053.
Testo completoAplenc, R., J. Blanco, W. Leisenring, S. Davies, M. Relling, L. Robison, C. Sklar, M. Stovall e S. Bhatia. "Polymorphisms in candidate genes in patients with congestive heart failure (CHF) after childhood cancer: A Report from the Childhood Cancer Survivor Study (CCSS)". Journal of Clinical Oncology 24, n. 18_suppl (20 giugno 2006): 9004. http://dx.doi.org/10.1200/jco.2006.24.18_suppl.9004.
Testo completoArmenian, Saro, e Smita Bhatia. "Predicting and Preventing Anthracycline-Related Cardiotoxicity". American Society of Clinical Oncology Educational Book, n. 38 (maggio 2018): 3–12. http://dx.doi.org/10.1200/edbk_100015.
Testo completoMata, Danilo Giffoni M. M., Matthew Castelo, Rinku Sutradhar, Lena Nguyen, Neil Faught, Danielle Rodin, Ezra Hahn et al. "Abstract P4-06-10: Is Anthracycline Chemotherapy Essential in the Treatment of Women with Breast Cancer? – A Real World Comparison in the Neoadjuvant Setting". Cancer Research 83, n. 5_Supplement (1 marzo 2023): P4–06–10—P4–06–10. http://dx.doi.org/10.1158/1538-7445.sabcs22-p4-06-10.
Testo completoHamilton, Joseph Z., Kerry Klussman, Rebecca Mahzereh, Jessica Simmons, Michelle Ulrich, Shyra J. Gardai, Peter D. Senter e Patrick J. Burke. "Abstract 2013: Oxidized anthracycline payloads induce anti-tumor immunogenic cell-death and show linker-dependent tolerability when delivered as ADCs". Cancer Research 83, n. 7_Supplement (4 aprile 2023): 2013. http://dx.doi.org/10.1158/1538-7445.am2023-2013.
Testo completoKremer, L. C. M., E. C. van Dalen, M. Offringa, J. Ottenkamp e P. A. Voûte. "Anthracycline-Induced Clinical Heart Failure in a Cohort of 607 Children: Long-Term Follow-Up Study". Journal of Clinical Oncology 19, n. 1 (1 gennaio 2001): 191–96. http://dx.doi.org/10.1200/jco.2001.19.1.191.
Testo completoFulbright, Joy Marie, e Joya Chandra. "“Limiting Anthracycline-Induced Cardiotoxicity Using Amrubicin in Leukemia Systems”." Blood 114, n. 22 (20 novembre 2009): 3760. http://dx.doi.org/10.1182/blood.v114.22.3760.3760.
Testo completoHarahsheh, Ashraf, Sanjeev Aggarwal, Michael D. Pettersen e Thomas L’Ecuyer. "Diastolic function in anthracycline-treated children". Cardiology in the Young 25, n. 6 (23 settembre 2014): 1130–35. http://dx.doi.org/10.1017/s1047951114001760.
Testo completoPiccart-Gebhart, Martine J., Tomasz Burzykowski, Marc Buyse, George Sledge, James Carmichael, Hans-Joachim Lück, John R. Mackey et al. "Taxanes Alone or in Combination With Anthracyclines As First-Line Therapy of Patients With Metastatic Breast Cancer". Journal of Clinical Oncology 26, n. 12 (20 aprile 2008): 1980–86. http://dx.doi.org/10.1200/jco.2007.10.8399.
Testo completoMegias-Vericat, Juan Eduardo, David Martínez-Cuadrón, Joaquin Martínez López, Juan Miguel Bergua, Mar Tormo, Josefina Serrano, Ataulfo González et al. "DIFFERENCES IN EX-VIVO CHEMOSENSITIVITY TO ANTHRACYCLINES IN FIRST LINE ACUTE MYELOID LEUKEMIA". Mediterranean Journal of Hematology and Infectious Diseases 11, n. 1 (26 febbraio 2019): e2019016. http://dx.doi.org/10.4084/mjhid.2019.016.
Testo completoCreutzig, Ursula, Sylke Diekamp, Martin Zimmermann e Dirk Reinhardt. "Long Term Data on Anthracycline Cardiotoxicity in 547 Children with AML." Blood 108, n. 11 (1 novembre 2006): 2014. http://dx.doi.org/10.1182/blood.v108.11.2014.2014.
Testo completoCheong, Alison, Sean McGrath e Suzanne Cutts. "Anthracyclines". WikiJournal of Medicine 5, n. 1 (6 dicembre 2018): 1. http://dx.doi.org/10.15347/wjm/2018.001.
Testo completo&NA;. "Anthracyclines". Reactions Weekly &NA;, n. 433 (gennaio 1993): 6. http://dx.doi.org/10.2165/00128415-199304330-00012.
Testo completo&NA;. "Anthracyclines". Reactions Weekly &NA;, n. 371 (ottobre 1991): 4–5. http://dx.doi.org/10.2165/00128415-199103710-00011.
Testo completo&NA;. "Anthracyclines". Reactions Weekly &NA;, n. 1293 (marzo 2010): 9–10. http://dx.doi.org/10.2165/00128415-201012930-00021.
Testo completoDesmedt, Christine, Angelo Di Leo, Evandro de Azambuja, Denis Larsimont, Benjamin Haibe-Kains, Jean Selleslags, Suzette Delaloge et al. "Multifactorial Approach to Predicting Resistance to Anthracyclines". Journal of Clinical Oncology 29, n. 12 (20 aprile 2011): 1578–86. http://dx.doi.org/10.1200/jco.2010.31.2231.
Testo completoCheah, Irwin K., Richard M. Y. Tang, Xiaoyuan Wang, Karishma Sachaphibulkij, Suet Yen Chong, Lina H. K. Lim, Jiong-Wei Wang e Barry Halliwell. "Protection against Doxorubicin-Induced Cardiotoxicity by Ergothioneine". Antioxidants 12, n. 2 (30 gennaio 2023): 320. http://dx.doi.org/10.3390/antiox12020320.
Testo completoAttina’, Giorgio, Silvia Triarico, Alberto Romano, Palma Maurizi, Stefano Mastrangelo e Antonio Ruggiero. "Serum Biomarkers for the Detection of Cardiac Dysfunction in Childhood Cancers Receiving Anthracycline-Based Treatment". Biomedical and Pharmacology Journal 15, n. 3 (29 settembre 2022): 1311–21. http://dx.doi.org/10.13005/bpj/2468.
Testo completoPaukovcekova, Silvia, Maria Krchniakova, Petr Chlapek, Jakub Neradil, Jan Skoda e Renata Veselska. "Thiosemicarbazones Can Act Synergistically with Anthracyclines to Downregulate CHEK1 Expression and Induce DNA Damage in Cell Lines Derived from Pediatric Solid Tumors". International Journal of Molecular Sciences 23, n. 15 (1 agosto 2022): 8549. http://dx.doi.org/10.3390/ijms23158549.
Testo completoFranco, Vivian I., Jacqueline M. Henkel, Tracie L. Miller e Steven E. Lipshultz. "Cardiovascular Effects in Childhood Cancer Survivors Treated with Anthracyclines". Cardiology Research and Practice 2011 (2011): 1–13. http://dx.doi.org/10.4061/2011/134679.
Testo completoPuzzovivo, Agata, Agnese Maria Fioretti, Carla Minoia, Roberta Villoni, Santa Carbonara, Giusi Graziano, Fabio Pavone, Attilio Guarini e Stefano Oliva. "Echocardiography Monitoring during Anthracycline Administration in Hodgkin and Non-Hodgkin’s Lymphoma: The Tei Index Evaluation". Journal of Personalized Medicine 12, n. 2 (16 febbraio 2022): 290. http://dx.doi.org/10.3390/jpm12020290.
Testo completoAngelotti, Austin, Deena Snoke, Rachel Cole, Genevieve Sparagna e Martha Belury. "Characterizing Cardiolipin Species in the Hearts After Anthracycline Administration". Current Developments in Nutrition 5, Supplement_2 (giugno 2021): 934. http://dx.doi.org/10.1093/cdn/nzab050_001.
Testo completoTagawa, Michihito, Genya Shimbo, Akiko Uemura e Kotaro Matsumoto. "Cardiomyopathy in a dog with multicentric lymphoma following treatment with several anthracyclines". Open Veterinary Journal 11, n. 1 (19 marzo 2021): 6–10. http://dx.doi.org/10.4314/ovj.v11i1.2.
Testo completoGschwantler-Kaulich, D., A. Fink-Retter, T. Bachrich, M. Ledesma, E. Ruecklinger, E. Kubista e C. F. Singer. "Efficacy of primary systemic chemotherapy regimen containing anthracyclines with/without taxanes in comparison to CMF in women with early breast cancer". Journal of Clinical Oncology 25, n. 18_suppl (20 giugno 2007): 11098. http://dx.doi.org/10.1200/jco.2007.25.18_suppl.11098.
Testo completoDadson, Keith, Oscar Calvillo-Argüelles, Paaladinesh Thavendiranathan e Filio Billia. "Anthracycline-induced cardiomyopathy: cellular and molecular mechanisms". Clinical Science 134, n. 13 (luglio 2020): 1859–85. http://dx.doi.org/10.1042/cs20190653.
Testo completoChong, Wei, Huikun Zhang, Zhifang Guo, Limin Yang, Ying Shao, Xiaoli Liu, Yawen Zhao et al. "Aquaporin 1 promotes sensitivity of anthracycline chemotherapy in breast cancer by inhibiting β-catenin degradation to enhance TopoIIα activity". Cell Death & Differentiation 28, n. 1 (19 agosto 2020): 382–400. http://dx.doi.org/10.1038/s41418-020-00607-9.
Testo completo